InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.31
(
0.22%
)
Bitcoin
64,165.39
(
0.26%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

fishypete

Send PM Follow Ignore
Followers 0
Posts 337
Boards Moderated 0
Alias Born 03/20/2002

fishypete

Re: None

Wednesday, 06/05/2002 11:47:38 AM

Wednesday, June 05, 2002 11:47:38 AM

Post# of 14671
EPA Grants BioShield Technologies New Use Approval for its Antimicrobial



RELATED SYMBOLS: (BSTI)

ATLANTA, Jun 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield
Technologies, Inc. (OTC Bulletin Board: BSTI) (http://www.bioshield.com )
announced today that the EPA has granted Approval for a new use application of
BioShield's Antimicrobial line of products for the $17 billion paints and
coatings industry. This New Use Approval significantly extends the use of
BioShield's product line as a spray on latex paints, stains, coatings, films,
laminates and finishes as well as directly added in can paints to control the
growth of bacteria, mold, mildew and algae for both indoor or outdoor use.

This New Use Approval provides BioShield with a quick entry into paints and
coatings industry, which includes: latex indoor and outdoor paints and stains;
woodstains, architectural paints; lacquer and maintenance coatings; films;
laminates and finishes including alkyd, urethane, enamel, epoxy, siloxaline,
amino resins, textile coatings, extrusion coatings, architectural coatings and
overlays, anti-corrosion coatings fire-resistant coatings, aliphatic coatings,
vinylester and polyester coatings, gel coatings, aminoresins, resins used as
additive mixes for cement, epoxy laminating resins and blends and copolymers; as
outlined in BioShield's EPA Registration #: 70871-12 with 19 claims approved by
the EPA for these new applications.

Management stated, "This new use approval and the use of BioShield's products
into paints and coatings demonstrates the strength, efficacy and broad range of
applications that our antimicrobials can be applied to. Obtaining this new
approval is a significant event for BioShield as it opens a whole new realm of
business to tap into and extends the sales opportunities for the Company, our
resellers and licensee partners. We're very excited about this new EPA Approval,
the value it creates for our company, and the potential that the $17 billion
paints and coatings industry holds for BioShield. The demand market for biocides
is forecast to be $204 million by 2004 (source "Disinfectant & Antimicrobial
Chemicals" The Freedonia Industry Study # 1442, July 2001)"

About BioShield Technologies, Inc.

BioShield Technologies, Inc., is a Norcross, Georgia-based emerging growth
company focused in biotechnology and antimicrobial products. Its core business
is committed to the discovery, development, marketing and sale of
surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily because
it kills bacteria, including HIV, on contact and can remain active for extended
time periods. To date BioShield has received three US patents and eight EPA
registrations, including the first U.S. germ killer and disinfectant against
Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The
company has developed several alliances in different industries, such as
healthcare, textiles and storm water.

Further information on BioShield and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com , or by calling
1-770-925-3653, Tim Moses.

Safe Harbor/Forward-looking Statements;

Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of BioShield; the result of research and development
efforts; future capital needs; uncertainty of additional funding; government
regulations; and other factors which are detailed in the company's periodic
reports and registration statements filed with the Securities and Exchange
Commission. BioShield does not undertake to revise or update any forward-looking
statement to reflect events or circumstances that may arise after the date
hereof. BioShield is a trademark of BioShield Technologies, Inc.


MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X47453868

SOURCE BioShield Technologies, Inc.


CONTACT: Tim Moses of BioShield, +1-770-925-3653

URL: http://www.bioshield.com
http://www.prnewswire.com

Copyright (C) 2002 PR Newswire. All rights reserved.

-0-


KEYWORD: Georgia
INDUSTRY KEYWORD: CHM
BIO
OTC

(Wall Street)




Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up